Last edition
News about
SmartCella Receives EUR 50 Million to Boost Commercialization of mRNA Operations
SmartCella Holding has announced a new share issue raising approximately EUR 50 million to accelerate growth and support commercialization of the Extroducer and the company's cell and mRNA operations.
Hinova Pharma Secures FDA Fast Track Designation for HP518
Hinova Pharmaceuticals Inc. has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for HP518, an investigational drug for the treatment of Androgen-receptor positive (AR+) triple-negative breast cancer (TNBC).
Ascentage Pharma Olverembatinib Gets Approval from ISAF for Commercialization in Macau China
Ascentage Pharma has announced that its BCR-ABL1 tyrosine kinase inhibitor (TKI), olverembatinib, has been approved by the Pharmaceutical Administration Bureau (ISAF) of the Macau Special Administrative Region (SAR) of the People's Republic of China.
Innovent Signs Agreement with IASO Bio for Cell Therapy
Innovent Biologics, Inc. and IASO Biotechnology have signed an agreement on a series of cooperation, including IASO Bio's purchase from Innovent regarding its relevant right of FUCASO (Equecabtagene Autoleucel) and obtaining license from Innovent regarding the intellectual property related to FUCASO, as well as Innovent's equity investment in IASO Bio.
Zydus Gets Tentative Approval from USFDA for Azilsartan Medoxomil Tablets
Zydus Lifesciences Ltd. has secured a tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil Tablets, 40 mg and 80 mg (USRLD: Edarbi tablets).
AbbVie Announces New Chief Executive Officer
AbbVie has announced that Robert A. Michael has assumed the role of chief executive officer (CEO) and has joined AbbVie's Board of Directors.
ChargePoint Technology UK Enters Indian Market with Localised Team
ChargePoint Technology UK has strengthened its global presence by establishing a localised team in India to support further its existing customers and the growing pharma manufacturing market.
Zydus and Dr. Reddy to Co-Market Pertuzumab Biosimilar in India
Zydus Lifesciences and Dr. Reddy’s Laboratories Ltd. have announced the execution of a licensing agreement to co-market Pertuzumab biosimilar in India.
EMA Approves Marketing Authorization Application of Nidlegy
Philogen and Sun Pharmaceutical Industries Ltd. have announced that the European Medicines Agency (EMA) validated the submission of the Marketing Authorization Application (MAA) for Nidlegy.
Alembic Pharma Gets Tentative Approval from FDA for Ivosidenib Tablets
Alembic Pharmaceuticals has received tentative approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ivosidenib Tablets, 250 mg.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy